GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS

SJ Schuster, MR Bishop, C Tam, EK Waller, P Borchmann, J McGuirk, U Jaeger, S Jaglowski, C Andreadis, J Westin, I Fleury, V Bachanova, SR Foley, PJ Ho, S Mielke, JM Magenau, H Holte, O Anak, L Pacaud, R Awasthi Show all